Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

SHE:300357 Revenue

Zhejiang Wolwo Bio-Pharmaceutical had revenue of 395.83M CNY in the quarter ending September 30, 2026, with 7.24% growth. This brings the company's total for the last twelve months to 1.12B, up 6.73% year-over-year. In the year 2025, Zhejiang Wolwo Bio-Pharmaceutical had annual revenue of 1.06B with 14.81% growth. That makes Zhejiang Wolwo Bio-Pharmaceutical the 18,756th largest company in the world by revenue and 3,433rd in China.

• Revenue (ttm): 1.12B
• Revenue Growth: +6.73%
• P/S Ratio: 9.88
• Revenue / Employee: 618.94K
• Employees: 1,808
• Market Cap: 11.05B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.06B	137.01M	14.81%
Dec 31, 2024	925.39M	77.20M	9.10%
Dec 31, 2023	848.19M	-47.83M	-5.34%
Jan 1, 2023	896.02M	88.32M	10.94%
Dec 31, 2021	807.69M	171.48M	26.95%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error